Your session is about to expire
← Back to Search
Behavioral Intervention
Skills-Based Resiliency Program for Caregivers of Coma Patients (COMA-F Trial)
N/A
Waitlist Available
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Caregivers must be age 18 or older
Caregivers must be English-speaking
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-test (6 weeks after session 1)
Awards & highlights
COMA-F Trial Summary
This trial tests a new way of helping people caring for those with severe brain injuries to better manage their stress. Data gathered will help make the program better.
Who is the study for?
This trial is for caregivers over 18 years old who speak English and are the primary caregiver of a patient with severe acute brain injury (like stroke or trauma) in ICU. The patient must be unable to communicate, have a low Glasgow Coma Scale score due to the injury, and expected to live more than 3 months without terminal illness.Check my eligibility
What is being tested?
The COMA-F program is being tested as an intervention for caregivers. It's designed to help them develop skills to handle emotional distress while caring for loved ones with severe brain injuries. This pilot study will refine the program based on participant feedback.See study design
What are the potential side effects?
Since COMA-F is a psychosocial skills-based intervention, it does not involve medication or medical procedures that typically cause side effects. However, discussing traumatic experiences could potentially lead to emotional discomfort.
COMA-F Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am a caregiver and I am 18 years old or older.
Select...
My caregiver speaks English.
Select...
I am caring for someone with a severe brain injury who cannot communicate.
COMA-F Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ post-test (6 weeks after session 1)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-test (6 weeks after session 1)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Preliminary feasibility of adherence
Preliminary feasibility of assessments
Preliminary feasibility of recruitment
+3 moreOther outcome measures
Cognitive and Affective Mindfulness Scale-Revised (CAMS-R)
Enhancing Recovery in Coronary Heart Disease Social Support Instrument (ESSI)
Hospital Anxiety and Depression Scale (HADS)
+3 moreCOMA-F Trial Design
1Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention
Caregivers will participate in 6 30-minute skills sessions. A clinical psychologist will deliver all of the sessions. The main intervention goal is to provide dyads with resiliency skills to reduce emotional distress and prevent chronic distress.
Find a Location
Who is running the clinical trial?
University of North Carolina, Chapel HillOTHER
1,504 Previous Clinical Trials
4,187,647 Total Patients Enrolled
1 Trials studying Coma
54 Patients Enrolled for Coma
Massachusetts General HospitalLead Sponsor
2,928 Previous Clinical Trials
13,198,340 Total Patients Enrolled
3 Trials studying Coma
113 Patients Enrolled for Coma
University of Maryland, BaltimoreOTHER
687 Previous Clinical Trials
374,631 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am a caregiver and I am 18 years old or older.My caregiver speaks English.I am caring for someone with a severe brain injury who cannot communicate.The person taking care of the patient has serious mental health issues that are not being treated or are not stable.I am the main caregiver for someone over 18 with a severe brain injury currently in ICU.The patient has a very serious illness that cannot be cured.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any remaining vacancies for participants in this medical experiment?
"According to the data hosted on clinicaltrials.gov, this particular medical study is not currently enrolling individuals; however, it was last edited on February 27th 2023. Luckily, there are 353 other trials that are accepting patients as of now."
Answered by AI
Share this study with friends
Copy Link
Messenger